1. Home
  2. SRI vs NBP Comparison

SRI vs NBP Comparison

Compare SRI & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

N/A

Current Price

$7.19

Market Cap

205.4M

ML Signal

N/A

NBP

NovaBridge Biosciences American Depositary Shares

N/A

Current Price

$1.63

Market Cap

205.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRI
NBP
Founded
1965
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.4M
205.9M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
SRI
NBP
Price
$7.19
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$16.00
$9.00
AVG Volume (30 Days)
89.5K
233.7K
Earning Date
05-01-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$4.60
$1.46
52 Week High
$9.71
$5.19

Technical Indicators

Market Signals
Indicator
SRI
NBP
Relative Strength Index (RSI) 49.27 34.87
Support Level $6.80 N/A
Resistance Level $7.51 $1.67
Average True Range (ATR) 0.22 0.07
MACD 0.00 -0.03
Stochastic Oscillator 52.19 0.00

Price Performance

Historical Comparison
SRI
NBP

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company generates key revenue from the United States.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Share on Social Networks: